发明公开
EP3002340A1 SPORULATION-DEFICIENT B. TEXASPORUS CELLS AND METHODS FOR EFFICIENT AND COST-EFFECTIVE INACTIVATION AND USE THEREOF
审中-公开
SPORULATIONSARME B. TEXASPORUS细胞和方法效率和成本效益失活和用途
- 专利标题： SPORULATION-DEFICIENT B. TEXASPORUS CELLS AND METHODS FOR EFFICIENT AND COST-EFFECTIVE INACTIVATION AND USE THEREOF
- 专利标题（中）： SPORULATIONSARME B. TEXASPORUS细胞和方法效率和成本效益失活和用途
-
申请号： EP15196151.3申请日： 2012-02-28
-
公开(公告)号： EP3002340A1公开(公告)日： 2016-04-06
- 发明人: JIANG, Yiwei
- 申请人： Mygalaxy Limited Company
- 申请人地址： 3801 Mattison Ave. B Fort Worth, TX 76107 US
- 专利权人： Mygalaxy Limited Company
- 当前专利权人： Mygalaxy Limited Company
- 当前专利权人地址： 3801 Mattison Ave. B Fort Worth, TX 76107 US
- 代理机构： Leonard, Thomas Charles
- 优先权： US201161447703P 20110301; US201213406202 20120227
- 主分类号： C12R1/07
- IPC分类号： C12R1/07 ; A61K35/742 ; C12N1/20 ; C12N1/36
摘要：
Novel strains and methods for their use are provided. Particularly, foods and other oral products or treatments containing sporulation deficient Bievibacillus strain when administered to a subject can inhibit or reduce the number of pathogens in the subject and improve the health of the subject.
信息查询
